SEC Form 4 · accession 0000059478-18-000042
ELI LILLY & Co · LLY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Susan Mahony
Officer — SVP & Pres., Lilly Oncology
Period of report
Jan 29, 2018
Accepted (ET)
Jan 31, 2018 · 6:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000059478
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 29, 2018 | A | 12,412 | $87.60 | A | 51,436 | D | |
| Common StockF1 | Jan 29, 2018 | A | 1,363 | $87.60 | A | 14,872 | I | by husband |
| Common Stock | holding | — | — | — | 1,725 | I | 401(k) | |
| Common StockF1 | holding | — | — | — | 1,714 | I | 401(k) - by husband |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF2 | — | Jan 29, 2018 | A | 11,111 | A | Feb 1, 2019 | Feb 1, 2019 | Common Stock | 11,111 | 11,111 | D |
Explanation of responses
- F1Reporting person disclaims beneficial ownership of these shares.
- F2Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.